2003•Unpublished venueRequires access

Clinical study on treating congestive heart failure with meglumine cyclic adenosine

Wei An

Abstract

Objective: To study the clinical effects of treating congestive heart failure with Meglumine Cyclic Adenosine. Methods: 100 inpatients with congestive heart failure (cardiac function NYHA Ⅲ - Ⅳ classes) were assigned randomly into two groups, the treatment group (50 cases) and the control group (50 cases). The treatment group was treated with MCA (150-180mg) in 5% dextrose(250ml)introvenously, once a day. The treatment for the control group was similar to that for the treatment group except MCA. Results: After a week's treatment, the total clinical effective rates for each group are 94% and 72% (P0.001). Conclusions: MCA is a new effective medicine in treatment of congestive heart failure

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Heart failure, Medicine, Cardiology, Meglumine, Cardiac function curve, Internal medicine, Clinical trial, Anesthesia